Sign in
4

Changes in Ownership

CalciMedica, Inc. Filed Acc 0001415889-24-011348

Options or other derivatives

  • Chief Scientific Officer acquired 62,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Stauderman Kenneth A. Chief Scientific Officer 2024-03-28 Grant or award · Employee Stock Option (Right to Buy) +62,500 62,500 D
Loading xslF345X05/form4-04232024_010428.xml…